UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000014246
Receipt No. R000016595
Official scientific title of the study Retrospective observational study about the effect of gastric acid suppressive drug on gastric mucosa
Date of disclosure of the study information 2014/06/12
Last modified on 2017/05/22 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Retrospective observational study about the effect of gastric acid suppressive drug on gastric mucosa
Title of the study (Brief title) Effect of gastric acid suppressive drug on gastric mucosa
Region
Japan

Condition
Condition gastritis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effect of gastric acid suppressive drug on gastric mucosa.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Histological change of gastric mucosa in the antrum and corpus.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 966 patients who performed upper GI endoscopy with gastric biopsy in order to investigate gastritis and H. pylori infection between Jan 1, 2010 and March 31, 2013 in Kawasaki Medical School.
Key exclusion criteria None
Target sample size 966

Research contact person
Name of lead principal investigator Tomoari Kamada
Organization Kawasaki Medical School
Division name Department of Internal Medicine, Division of Gastroenterology
Address 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan,
TEL 086-462-1111
Email tkamada@med.kawasaki-m.ac.jp

Public contact
Name of contact person Tomoari Kamada
Organization Kawasaki Medical School
Division name Department of Internal Medicine, Division of Gastroenterology
Address 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan,
TEL 086-462-1111
Homepage URL
Email tkamada@med.kawasaki-m.ac.jp

Sponsor
Institute Kawasaki Medical School
Institute
Department

Funding Source
Organization Astellas Pharma Inc
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 06 Month 12 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 04 Month 01 Day
Anticipated trial start date
2014 Year 04 Month 14 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2017 Year 03 Month 31 Day
Date trial data considered complete
2017 Year 03 Month 31 Day
Date analysis concluded
2017 Year 05 Month 31 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information None

Management information
Registered date
2014 Year 06 Month 12 Day
Last modified on
2017 Year 05 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016595